若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

环状 Pifithrin-α(Cyclic Pifithrin-Alpha)

p53抑制剂

产品号 #(选择产品)

产品号 #72062_C

p53抑制剂

总览

环状Pifthrin-Alpha是一种可渗透细胞且可逆的p53介导的细胞凋亡和p53依赖性基因转录抑制剂。它是非环状Pifithrin-Alpha的更稳定且细胞毒性更低的类似物。据报道,环状Pifithrin-Alpha还可激活芳烃受体(Fernandez-Cruz et al., Gary & Jensen, Komarov et al.)。

重编程
·提高小鼠胚胎成纤维细胞重编程为诱导多能干细胞的效率(Liao et al.)。

维持和自我更新
·降低紫外线诱导的小鼠胚胎干细胞凋亡(Qin et al.)。
·增加小鼠体内和体外造血干细胞和祖细胞的数量,并降低辐射诱导的这些细胞死亡(Leonova et al.)。

别名
环状PFT-α,环状Pifithrin-α,PFT-β,Pifithrin-β
 
细胞类型
造血干/祖细胞,多能干细胞
 
种属
人,小鼠,非人灵长类,其它细胞系,大鼠
 
应用
扩增,培养,重编程
 
研究领域
干细胞生物学
 
CAS 编号
511296-88-1
 
化学式
C₁₆H₁₆N₂S · HBr
 
分子量
349.3 克/摩尔
 
纯度
≥ 95 %
 
通路
p53
 
靶点
p53
 

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
72064
Lot #
All
Language
English
Catalog #
72062
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
72064
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
72062
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计,适用于工作流程中的高亮阶段。探索这些工作流程,了解更多我们为各研究领域提供的其他配套产品。

相关材料与文献

技术资料 (3)

文献 (6)

Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells. Liao J et al. Molecular therapy : the journal of the American Society of Gene Therapy 2013 JUN

Abstract

Induced pluripotent stem cells (iPSCs) can be generated from patients with specific diseases by the transduction of reprogramming factors and can be useful as a cell source for cell transplantation therapy for various diseases with impaired organs. However, the low efficiency of iPSC derived from somatic cells (0.01-0.1%) is one of the major problems in the field. The phosphoinositide 3-kinase (PI3K) pathway is thought to be important for self-renewal, proliferation, and maintenance of embryonic stem cells (ESCs), but the contribution of this pathway or its well-known negative regulator, phosphatase, and tensin homolog deleted on chromosome ten (Pten), to somatic cell reprogramming remains largely unknown. Here, we show that activation of the PI3K pathway by the Pten inhibitor, dipotassium bisperoxo(5-hydroxypyridine-2-carboxyl)oxovanadate, improves the efficiency of germline-competent iPSC derivation from mouse somatic cells. This simple method provides a new approach for efficient generation of iPSCs.
Biological and chemical studies on aryl hydrocarbon receptor induction by the p53 inhibitor pifithrin-α and its condensation product pifithrin-β. Ferná et al. Life sciences 2011 APR

Abstract

AIMS Pifithrin α (PFTα), an inhibitor of the p53 protein, is regarded as a lead compound for cancer and neurodegenerative disease therapy. There is some evidence that this compound activates the aryl hydrocarbon receptor (AhR) in a complete independent way of the p53 inhibition and that it is easily converted to its condensation product pifithrin β (PFTβ). The aim of this study was to explore the ability of PFTα and of PFTβ to induce a variety of AhR mediated processes. MAIN METHODS Computational analysis using quantum chemical calculations and chemical analysis have been used to study the conformation of the compounds as well as the cyclization reaction. The AhR mediated processes of these compounds have been studied in a rainbow trout cell line (RTG-2) and in a rat hepatoma cell line (H4IIE). KEY FINDINGS PFTα molecule could not take a planar conformation required for AhR activation whereas PFTβ showed a conformation similar to those of the prototypical AhR ligand β-naphthoflavone. In both cell lines, PFTα and PFTβ provoked different responses related with AhR activation. However, when cyclization of PFTα to PFTβ was hampered by acetylation of the exocyclic nitrogen, all these responses were not observed. These results lead to the conclusion that the activation of the AhR is probably caused by PFTβ instead of PFTα. SIGNIFICANCE Since PFTα is a promising compound for the development of new pharmaceuticals inhibiting p53, the chemical instability of this compound as well as the capacity of its transformation product should be taken into account.
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice. Leonova KI et al. Cell cycle (Georgetown, Tex.) 2010 APR

Abstract

It has been shown that genetic inhibition of p53 leads to enhanced proliferation of hematopoietic stem cells (HSCs). This could, in theory, contribute to the increased frequency of tumor development observed in p53-deficient mice and humans. In our previous work, we identified chemical p53 inhibitors (PFTs) that suppress the transactivation function of p53 and protect cultured cells and mice from death induced by gamma irradiation (IR). Here we found that when applied to bone marrow cells in vitro or injected into mice, PFTb impeded IR-induced reduction of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) population sizes. In addition, we showed that PFTb stimulated HSC and HPC proliferation in the absence of IR in vitro and in vivo and mobilized HSCs to the peripheral blood. Importantly, however, PFTb treatment did not affect the timing or frequency of tumor development in irradiated p53 heterozygous mice used as a model for determination of carcinogenicity. Thus, although PFTb administration led to increased numbers of HSCs and HPCs, it was not carcinogenic in mice. These findings suggest that chemical p53 inhibitors may be clinically useful as safe and effective stimulators of hematopoiesis.

更多信息

更多信息
Molecular Weight 349.3 g/mol
种属 Human, Mouse, Non-Human Primate, Other, Rat
Alternative Names Cyclic PFT-α, Cyclic Pifithrin-α, PFT-β, Pifithrin-β
Cas Number 511296-88-1
Chemical Formula C₁₆H₁₆N₂S · HBr
纯度 ≥ 95%
Target p53
Pathway p53
质量保证:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。
Copyright © 2025 by STEMCELL Technologies. All rights reserved.